Gumus, MahmutGeredeli, CaglayanUcar, MahmutKaya, SerapDemir, HacerUnal, Olcun UmitDegirmenci, MustafaDogu, Gamze GokozTuran, NedimYildirim, NilgunBasal, Fatma BugdayciArpaci, ErkanKaraagac, MustafaHarputluoglu, HakanTurk, Had MehmetDane, FaysalOzkan, Metin2019-07-272019-07-282019-07-272019-07-2820170732-183X1527-7755https://dx.doi.org/10.1200/JCO.2017.35.15_suppl.e15028https://hdl.handle.net/20.500.12418/678253rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET -- JUN 02-07, 2017 -- Chicago, IL…en10.1200/JCO.2017.35.15_suppl.e15028info:eu-repo/semantics/closedAccessEGFR-targeted treatments in patients with metastatic colorectal cancer: Experience of panitumumab.Conference Object35WOS:000411895707135Q1